European regulators recommend rejection of Merck’s Covid-19 drug molnupiravir –
European regulators recommend rejection of Merck's Covid-19 drug molnupiravir Endpoints NewsEurope's CHMP advises against authorization of Merck's Lagevrio FiercePharmaMerck ...